MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2025 International Congress
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2017 International Congress

    The Life Style and Risk of Parkinson Disease

    R. Pinzon (Yogyakarta, Indonesia)

    Objective: The aim of this study is identify the risk factors of Parkinson Disease related with life style (history of head trauma, tea consumption, coffee…
  • 2017 International Congress

    Gastrointestinal transit time in Parkinson’s disease -a novel 3D method

    K. Knudsen, T. Fedorova, K. Østergaard, K. Krogh, P. Borghammer (Aarhus, Denmark)

    Objective: To study the GI transit time with a novel ambulatory electromagnetic system in PD patients and healthy controls. Background: The majority of Parkinson’s disease…
  • 2017 International Congress

    Motor and non-motor symptoms in old-age onset Parkinson’s Disease patients

    M. Mendonça, T. Lampreia, R. Miguel, A. Caetano, R. Barbosa, P. Bugalho (Lisboa, Portugal)

    Objective: Understand the role of old-age onset in Parkinson’s Disease (PD) motor and non-motor phenotype.  Background: Advancing age is a risk factor for PD. With…
  • 2017 International Congress

    Videoendoscopy study of swallowing in Parkinson’s disease

    J. Fukae, Y. Tsuboi, S. Fujioka, G. Umemoto (Fukuoka, Japan)

    Objective: We make a hypothesis that dysphagia of anti-parkinsonian drugs may be associated with motor fluctuation, especially delay on. In this study, we compared videoendoscopy…
  • 2017 International Congress

    Diagnosis of Irritable Bowel Syndrome Increases Risk of Parkinson’s Disease in the Finnish Population

    T. Mertsalmi, E. Pekkonen, F. Scheperjans (HUS, Finland)

    Objective: To assess risk of Parkinson’s disease in patients with irritable bowel syndrome in the Finnish population. Background: The majority of Parkinson’s disease (PD) patients…
  • 2017 International Congress

    AAV-mediated human alpha synuclein overexpression in the locus coeruleus (LC) leads to a neuronal loss in the nucleus ambiguus of mouse.

    B. Lee, M. Henrich, W.-H. Chiu, L. Matschke (Marburg, Germany)

    Objective: To investigate the impact and temporal aspects of the neuronal loss in the LC neurons induced by alpha-synucleinopathy Background: In the Braak staging model…
  • 2017 International Congress

    Efficacy of Tozadenant in Animal Models of Non-Motor Symptoms of Parkinson’s Disease

    C. Kostrub, C. Kenney, C. Riemer, E. Prinssen, A. Flohr, J.-L. Moreau (Ardsley, NY, USA)

    Objective: Investigate the potential of tozadenant (TOZ) to alleviate the non-motor symptoms of Parkinson's disease using multiple animal models. Background: TOZ is an oral, selective…
  • 2017 International Congress

    Long-term Effects of Subthalamic Nucleus Deep Brain Stimulation on Quality of Life, Non-motor and Motor Symptoms

    H. Dafsari, J. Petry-Schmelzer, M. Strack, L. Stalinski, V. Visser-Vandewalle, A. Rizos, M. Silverdale, K. Ashkan, M. Samuel, J. Evans, A. Antonini, P. Martinez-Martin, K. Ray Chaudhuri, L. Timmermann (Cologne, Germany)

    Objective: To study the long-term effects of bilateral subthalamic deep brain stimulation (STN-DBS) on Quality of Life (QoL), motor, non-motor symptoms (NMS) in patients with…
  • 2017 International Congress

    Lower education level is associated with greater disability from pain in Parkinson’s disease patients

    A.Q. Rana, A.R. Qureshi, Z. Sarfaraz, R. Rana (Toronto, ON, Canada)

    Objective: The objective of the current study is to explore whether a relationship between the level of educational attainment and degree of disability from pain…
  • 2017 International Congress

    [11C]PK11195 PET in Alzheimer’s disease and progressive supranuclear palsy: the NIMROD study

    P. Vazquez Rodriguez, J. Rowe, J. O'Brien, F. Aigbirhio, T. Fryer, L. Su, E. Mak, A. Surendranathan, R. Borchert, S. Jones, R. Arnold, R. Bevan-Jones, L. Passamonti, Y. Hong (Cambridge, United Kingdom)

    Objective: Here we test whether the intensity and regional distribution of neuro-inflammation differs between Alzheimer's disease (AD), Progressive Supranuclear Palsy (PSP) and controls; and whether neuro-inflammation…
  • « Previous Page
  • 1
  • …
  • 96
  • 97
  • 98
  • 99
  • 100
  • …
  • 155
  • Next Page »

Most Viewed Abstracts

  • This Month
  • All Time
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • “Magic carpet for freezing of gait ” Evaluating a combination of patterned and pictographic visual cues.
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Effect of marijuana on Essential Tremor: A case report
  • Increased Risks of Botulinum Toxin Injection in Patients with Hypermobility Ehlers Danlos Syndrome: A Case Series
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley